STRO - Financial Reports List - Sutro Biopharma, Inc. - IntrinsicAlpha

Sutro Biopharma, Inc. STRO

Healthcare - Biotechnology - NASDAQ - US

$ 0.6321

5.28 %

$ 53.3 M

Market Cap

-0.19

P/E

FINANCIAL REPORTS

Reports

Report			Date	Revenue YoY	Net Income YoY	Operating Income YoY	View
Quarterly Report	Q4	8-K	2024-12-31	-86.98%	-233.20%	-151.23%
Annual Report	FY	10-K	2024-12-31	-59.64%	-112.99%	-167.09%
Quarterly Report	Q3	8-K	2024-09-30	-49.66%	1.01%	-54.31%
Quarterly Report	Q2	8-K	2024-06-30	146.89%	-24.64%	-5.43%
Quarterly Report	Q1	8-K	2024-03-31	2.64%	-16.31%	-33.98%
Quarterly Report	Q4	8-K	2023-12-31	1217.44%	183.75%	187.67%
Annual Report	FY	10-K	2023-12-31	126.84%	10.41%	30.76%
Quarterly Report	Q3	8-K	2023-09-30	-32.70%	-177.41%	-107.52%
Quarterly Report	Q2	8-K	2023-06-30	-62.94%	-48.10%	-138.29%
Quarterly Report	Q1	8-K	2023-03-31	114.92%	-28.04%	-7.93%

1